Mankind Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)
Mankind Pharma Ltd · Outcome · 26 Oct 2026, 8:37 pm
Mankind Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 4,338 (+17.3% YoY | +7.6% QoQ) ■ EBITDA: 1,171 (+27.1% YoY | +10.9% QoQ) ■ EBITDA Margin (%): 27.0 (+208 bps YoY | +80 bps QoQ) ■ PAT: 711 (+39.1% YoY | +25.2% QoQ) ■ EPS (INR): 17.2 (+38.9% YoY | +25.2% QoQ)
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA · 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference · 06 Nov 2026
- Please find attached intimation regarding ESG Rating · 05 Nov 2026
- Intimation of participation in the Investor Conference. · 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 · 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL · 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet · 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 · 27 Oct 2026
